Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04088890
Title Autologous CD22 CAR T Cells in Adults w/ Recurrent or Refractory B Cell Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Stanford University
Indications

acute lymphoblastic leukemia

primary mediastinal B-cell lymphoma

diffuse large B-cell lymphoma

Therapies

Anti-CD22 CAR T cells

Cyclophosphamide + Fludarabine

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.